desloratadine has been researched along with fosinopril in 2 studies
| Studies (desloratadine) | Trials (desloratadine) | Recent Studies (post-2010) (desloratadine) | Studies (fosinopril) | Trials (fosinopril) | Recent Studies (post-2010) (fosinopril) |
|---|---|---|---|---|---|
| 465 | 146 | 166 | 10 | 0 | 3 |
| 465 | 146 | 166 | 433 | 154 | 50 |
| Protein | Taxonomy | desloratadine (IC50) | fosinopril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bain, LJ; Green, BR | 1 |
1 review(s) available for desloratadine and fosinopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for desloratadine and fosinopril
| Article | Year |
|---|---|
Mrp2 is involved in the efflux and disposition of fosinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; ATP-Binding Cassette Transporters; Biological Transport, Active; Cell Line; Cell Survival; Dogs; Drug Interactions; Folic Acid Antagonists; Fosinopril; Histamine H1 Antagonists; Humans; Loratadine; Methotrexate; Mice; Mice, Knockout; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Tissue Distribution | 2013 |